Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
about
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.Enumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering.Evolutionary gain of function for the ER membrane protein Sec62 from yeast to humansThe chromosome 3q26 OncCassette: A multigenic driver of human cancer.Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma.Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysisSki and SnoN, potent negative regulators of TGF-beta signaling.All roads lead to Rome (but some may be harder to travel): SRP-independent translocation into the endoplasmic reticulum.Protein transport into the human ER and related diseases, Sec61-channelopathies.Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.Hypoxia and Selective Autophagy in Cancer Development and Therapy
P2860
Q33294835-8F473CBB-67D4-44EA-992D-F1929EA3D6B2Q33669571-C231A58B-1CFE-4CB5-AD13-75A4EDDBA223Q33689768-5C00B56E-E035-4B23-9E8C-7D8589087782Q36510237-1AD32F1F-BACD-46B5-9750-1883D8BF1E4DQ36640322-CF8C1497-81C3-41CE-9F4F-2D611D3C090EQ36686743-A46D2BDA-5891-4942-AE22-ECA3FEC6A54EQ37359949-1E41F15D-8908-40F8-AE12-E98B3F02078DQ38093231-A4F4AC21-F7FB-4B13-A971-C73D6B9BD47DQ38220635-166FCF78-9794-43FF-9891-FC883773B8C8Q38516787-C5C196F9-7E2A-42E7-B856-51F219F8982CQ39186868-BA8A524E-0AC5-4245-A00F-E57B8655210CQ39545346-6BDE56F2-1E6E-415F-B039-DD7BFAE434A4Q39673958-899F1D5F-2564-4A7B-A056-9D16F9A1EF0AQ39908058-8A05F70B-AAEC-4F06-BA96-879CE344DE4FQ48272400-E6EBE266-7893-4626-AB00-DBA832AC98A0Q58754296-DFC824BC-2791-4542-B837-8C0A008D4D2C
P2860
Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Genomic and expression analysi ...... arget gene in prostate cancer.
@ast
Genomic and expression analysi ...... arget gene in prostate cancer.
@en
Genomic and expression analysi ...... arget gene in prostate cancer.
@nl
type
label
Genomic and expression analysi ...... arget gene in prostate cancer.
@ast
Genomic and expression analysi ...... arget gene in prostate cancer.
@en
Genomic and expression analysi ...... arget gene in prostate cancer.
@nl
prefLabel
Genomic and expression analysi ...... arget gene in prostate cancer.
@ast
Genomic and expression analysi ...... arget gene in prostate cancer.
@en
Genomic and expression analysi ...... arget gene in prostate cancer.
@nl
P2093
P1476
Genomic and expression analysi ...... target gene in prostate cancer
@en
P2093
Bernd Wullich
Gerhard Unteregger
Jörn Kamradt
Martin Jung
Michael Stöckle
Mirko Müller
Rainer Engers
Richard Zimmermann
Roland Kindich
Volker Jung
P304
P356
10.1158/1541-7786.MCR-05-0165
P577
2006-03-01T00:00:00Z